A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

<p>Abstract</p> <p>Background</p> <p>In 2001, two hexavalent vaccines were licensed in Italy (Hexavac^®, Infanrix Hexa^®), and since 2002 were extensively used for primary immunization in the first year of life (at 3, 5, 11/12 months of age). In 2005, the market authorization of...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Chionne Paola, Rapicetta Maria, Oddone Maurizio, Zito Salvatore, Marchisio Maria, Montù Domenico, Barale Antonella, Bella Antonino, Giambi Cristina, Madonna Elisabetta, Atti Marta
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2008-07-01
Edice:	BMC Infectious Diseases
On-line přístup:	http://www.biomedcentral.com/1471-2334/8/100
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!